cancers-logo

Journal Browser

Journal Browser

Announcements

14 April 2025
Welcoming New Editorial Board Members of Cancers Joined in February 2025

We are pleased to announce that seven new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in February 2025. We wish our new members success in both their research and their efforts to develop the journal.

Name: Prof. Dr. Muy-Teck Teh
Affiliation: 1 Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts; 2 The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Interests: molecular diagnostics; cancer biomarkers; transcriptomics; foxm1; qmids digital cancer test

Name: Prof. Dr. Thomas Ming Swi Chang
Affiliation: 1 Artificial Cells and Organs Research Centre, Faculty of Medicine and Medical Sciences; 2 McGill University, Montreal, QC H3G1Y6, Canada
Interests: artificial cells; biomaterials; blood substitutes; drug delivery; microencapsulation; enzyme engineering

Name: Dr. Dario Baratti
Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Interests: hyperthermic intraperitoneal chemotherapy; cytoreductive surgery; peritoneum tumor; peritoneal malignancies; colorectal cancer

Name: Dr. Chiara Laezza
Affiliation: Consiglio Nazionale delle Ricerche, IEOS, CNR, 80145 Naples, Italy
Interests: mevalonate pathway; prenylation proteins; cannabinoid and cancer; cell cycle; cancer-related biochemical pathways; cell proliferation; cell signaling; breast cancer; glioblastoma multiforme

Name: Prof. Dr. Cesare Gridelli
Affiliation: Division of Medical Oncology, S.G. Moscati Hospital, 83100 Avellino, Italy
Interests: lung cancer; non-small cell lung cancer; targeted therapies; immunotherapy

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

  • A full academic CV;
  • A short cover letter detailing your interest in the position.

7 April 2025
World Health Day—“Healthy Beginnings, Hopeful Futures”, 7 April 2025


World Health Day aims to draw global attention to pressing health challenges, reinforcing our commitment to the United Nations’ Sustainable Development Goal 3—ensuring healthy lives and promoting well-being for all.

This year’s theme, “Healthy Beginnings, Hopeful Futures” highlights the importance of maternal and infant health. Current estimates show that a woman dies every two minutes from preventable causes related to pregnancy and childbirth. Urgent action is needed to end preventable maternal and newborn deaths and to prioritize women’s long-term health and well-being.

To provide high-quality care before, during, and after childbirth, we must engage in critical discussions and foster collaboration among researchers, policymakers, and healthcare professionals. Health systems must evolve to address the full spectrum of maternal and newborn health issues—from obstetric complications to mental health conditions, noncommunicable diseases, and family planning.

In recognition of World Health Day 2025, we invite you to explore a curated selection of articles, journals, and Special Issues spanning multiple disciplines. These resources offer valuable insights into the complexities of maternal and infant health and outline actionable steps toward lasting, positive change.

Together, we can build a world where every mother and child have the opportunity for a healthy, hopeful future.

Medicine & Pharmacology

Public Health & Healthcare

Biology & Life Sciences

Social Sciences, Arts & Humanities

Maternal Health
Relationship Between Plasma Acid Sphingomyelinase and Alteration in Taste and Smell as Indicator of Long COVID in Pregnant Women
by Federico Fiorani, Giulia Moretti, Laura Cerquiglini, Chiara Gizzi, Giulia Gizzi, Paola Signorelli, Samuela Cataldi, Tommaso Beccari, Elisa Delvecchio, Claudia Mazzeschi et al.
Reports 2024, 7(4), 104; https://doi.org/10.3390/reports7040104
  
Pregnant Women’s Perception of Gestational Anemia and Iron Supplements in Oman
by Zalikha Khamis Al-Marzouqi, Nawal Said Alsereahi and Safiya Khalfan Al Maqbali
J. Oman Med. Assoc. 2024, 1(1), 10–22; https://doi.org/10.3390/joma1010003

The Sri Lanka Mother and Newborn Growth (S-MaNGro) Cohort: Protocol of a Nationwide Prospective Study
by Malshani Lakshika Pathirathna, Megumi Haruna, Satoshi Sasaki, Kaori Yonezawa, Yuriko Usui and Yasuhiro Hagiwara
Methods Protoc. 2024, 7(4), 61; https://doi.org/10.3390/mps7040061

Gestational Trophoblastic Disease: Complete versus Partial Hydatidiform Moles
by Jeffrey Gonzalez, Meagan Popp, Stephanie Ocejo, Alvaro Abreu, Hisham F. Bahmad and Robert Poppiti
Diseases 2024, 12(7), 159; https://doi.org/10.3390/diseases12070159

Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective
by Lucia Stančiaková, Kristína Brisudová, Ingrid Škorňová, Tomáš Bolek, Matej Samoš, Kamil Biringer, Ján Staško and Juraj Sokol
Pharmaceuticals 2024, 17(6), 773; https://doi.org/10.3390/ph17060773

Caring for Pregnant Patients with Cancer: A Framework for Ethical and Patient-Centred Care
by Alma Linkeviciute, Rita Canario, Fedro Alessandro Peccatori and Kris Dierickx
Cancers 2024, 16(2), 455; https://doi.org/10.3390/cancers16020455

Histopathological Clues of Enhanced Inflammation in the Placental Tissue of Women with Chronic Venous Disease in Lower Limbs during Pregnancy
by María Asunción Sánchez-Gil, Oscar Fraile-Martinez, Cielo García-Montero, María Del Val Toledo, Luis G. Guijarro, Juan A. De León-Luis, Coral Bravo, Raúl Díaz-Pedrero, Laura López-Gonzalez, Miguel A. Saez et al.
J. Pers. Med. 2024, 14(1), 87; https://doi.org/10.3390/jpm14010087

Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project
by Martje Van Neste, Annick Bogaerts, Nina Nauwelaerts, Julia Macente, Anne Smits, Pieter Annaert and Karel Allegaert
Pharmaceutics 2023, 15(11), 2618; https://doi.org/10.3390/pharmaceutics15112618

Umbilical Cord Diseases Affecting Obstetric and Perinatal Outcomes
by Gabriele Tonni, Mario Lituania, Alessandro Cecchi, Elisa Carboni, Serena Resta, Maria Paola Bonasoni and Rodrigo Ruano
Healthcare 2023, 11(19), 2634; https://doi.org/10.3390/healthcare11192634

Scientists’ Warning: Remove the Barriers to Contraception Access, for Health of Women and the Planet
by Jan Greguš and John Guillebaud
World 2023, 4(3), 589–597; https://doi.org/10.3390/world4030036

Trauma-Informed Care and Equity in Group Pregnancy Care for Women of Refugee Background: Reflections from the Workforce
by Fran Hearn, Laura Biggs, Stephanie J. Brown, Ann Krastev, Josef Szwarc and Elisha Riggs
Trauma Care 2023, 3(3), 161–176; https://doi.org/10.3390/traumacare3030016

Smoking Cessation Rates among Pregnant Women and Their Relapse Rates in the Postpartum Period in Samsun
by Bektas Murat Yalcin, Tugba Kertmen and Muge Ustaoglu
J. Respir. 2023, 3(3), 118–129; https://doi.org/10.3390/jor3030012

Effects of COVID-19 on Kenya’s Healthcare System: Healthcare Providers’ Experiences with Maternal Health Services Utilization in Coastal Kenya
by Stephen Okumu Ombere and Agnetta Adiedo Nyabundi
World 2023, 4(1), 140152; https://doi.org/10.3390/world4010010

Infant and Child Health
Clinical Insight into Congenital Hypothyroidism Among Children
by Hüseyin Anıl Korkmaz
Children 2025, 12(1), 55; https://doi.org/10.3390/children12010055

Child and Adolescent Mental Health in a Period of Fewer COVID-19-Related Restrictions in an Urban Population in Germany
by Anna Konopka, Amand Führer, Mascha Binder, Sophie Diexer, Thomas Frese, Michael Gekle, Matthias Girndt, Cornelia Gottschick, Jessica Hoell, Bianca Klee et al.
Psychiatry Int. 2024, 5(4), 718–737; https://doi.org/10.3390/psychiatryint5040050

Differences in Farmers’ Market Patronage among Participants in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC)
by Renata Blumberg, Emily Fowler, Gabrielle Guerrero, Yeon Bai, Meena Mahadevan and Pankaj Lal
Dietetics 2024, 3(2), 179–190; https://doi.org/10.3390/dietetics3020015

Maternal Depressive Symptoms in the First Year after Childbirth Predict Long-Term Developmental Risks in Sons and Daughters
by Linda S. Pagani, Kianoush Harandian, Beatrice Necsa, Marie-Josée Harbec and George M. Tarabulsy
Int. J. Environ. Res. Public Health 2024, 21(3), 264; https://doi.org/10.3390/ijerph21030264

Inflammatory Biomarker Profiles in Very Preterm Infants within the Context of Preeclampsia, Chorioamnionitis, and Clinically Diagnosed Postnatal Infection
by Jordan T. Ewald, Baiba Steinbrekera, Jennifer R. Bermick, Donna A. Santillan, Tarah T. Colaizy, Mark K. Santillan and Robert D. Roghair
Pediatr. Rep. 2023, 15(3), 483–493; https://doi.org/10.3390/pediatric15030044

A Pilot Randomised Controlled Trial Evaluating a Regenerative Epithelial Suspension for Medium-Size Partial-Thickness Burns in Children: The BRACS Trial
by Anjana Bairagi, Zephanie Tyack, Roy Kimble, Dimitrios Vagenas, Steven M. McPhail and Bronwyn Griffin
Eur. Burn J. 2023, 4(1), 121–141; https://doi.org/10.3390/ebj4010012

The Impact of the Early COVID-19 Global Pandemic on Children Undergoing Active Cancer Treatment and Their Parents
by Andrew Tran, Sharon H. J. Hou, Caitlin Forbes, Sara Cho, Victoria J. Forster, Mehak Stokoe, Claire E. Wakefield, Lori Wiener, Lauren C. Heathcote, Gisela Michel et al.
Curr. Oncol. 2023, 30(2), 2441–2456; https://doi.org/10.3390/curroncol30020186

Feature Advancements in Section “Childhood, Adolescent and Young Adult Oncology”

Global Neonatal Screening: Expanding Horizons in Diagnostic Technologies

Healthy Lifestyle for Pregnant and Postpartum Women

Advanced Pediatric Drug Formulation Strategies

 

 

 

3 April 2025
Meet Us at the 62nd ERA Congress, 4–7 June 2025, Vienna, Austria


MDPI is pleased to announce our participation in the 62nd ERA Congress, which will be held from 4 to 7 June 2025 in Vienna, Austria.

The 62nd ERA Congress will revolve around the theme of “Game Changers in Nephrology”. The seven main tracks can be explored via the following link: https://www.era-online.org/events/vienna-2025/scientific-programme/.

The following MDPI journals will be represented:

If you are attending the 62nd ERA Congress, we invite you to visit us at booth X3.380. Our representatives, Mr. Peter Roth and Dr. Jennie Xu, look forward to meeting you in person at the booth and answering any questions that you may have.

For more information about the conference, please visit its official website: https://www.era-online.org/events/vienna-2025/.

2 April 2025
MDPI INSIGHTS: The CEO's Letter #21 - Annual Report, Swiss Consortium, IWD, ICARS, Serbia

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Releases 2024 Annual Achievements Report

I’m pleased to share the release of MDPI’s 2024 Annual Achievements Report, which reflects our commitment to efficiency, transparency, and excellence in scholarly communication. The report showcases key themes related to our growth (highlighting our workforce expansion, new offices, journal milestones), excellence (editorial and publishing advancements), people (talent development and training), and community (partnerships, conferences, and outreach).

MDPI continues to build connections and drive scientific progress

Our mission remains clear: to support researchers worldwide by delivering an efficient, high-quality publishing experience while strengthening the global Open Access (OA) movement.

Advancing Open Access: A Global Knowledge Hub

In 2024, we published 238,000 peer-reviewed OA articles, reaching over 25 million downloads. This reinforces MDPI’s role as a global knowledge hub, breaking down barriers to access and ensuring that high-quality research is freely available to everyone. As part of the OA movement, we are actively democratizing knowledge, making scientific advancements accessible to researchers, policymakers, educators, and the public, without the restrictions of traditional paywalls.

Expanding our Workforce and Strengthening Research Integrity

Our global presence grew in 2024 with the opening of a new Seoul office, and our workforce expanded to 6,650 staff across 21 offices. This reflects our continued growth mindset and investment in global accessibility. We also continued to take a proactive stance on our commitment to research integrity, tripling our team in this area and joining STM’s Integrity Hub and United2Act. This means more rigorous quality control, stronger safeguards, and collaboration with global initiatives to detect and combat unethical publishing practices at an industry level. Our growth is about reinforcing our role as a trusted, ethical, and accessible publishing platform for researchers worldwide.

Growing Partnerships and Impact in Scholarly Communication

MDPI’s partnerships continue to thrive, with over 900 institutional collaborations, including a landmark agreement with ZB MED in Germany, covering more than 100 universities. Additionally, more than 90% of evaluated MDPI journals have been accepted into Web of Science, including 60 new acceptances in 2024, with nearly 300 journals expected to receive a Journal Impact Factor in 2025. In the same period, 37 MDPI journals were accepted into Scopus, bringing our total indexed titles to 306. Most importantly, 95% of authors rate their experience with MDPI as excellent or good – an achievement that underscores our dedication to serving the research community.

I encourage you to read through our Annual Report, which highlights these milestones and our vision for the future. Thank you for being part of MDPI’s journey in advancing open science.

Impactful Research

MDPI Renews Partnership with CSAL to Support Swiss Universities

I am pleased to announce the renewal of our partnership with the Consortium of Swiss Academic Libraries (CSAL) for 2025. This extension reinforces MDPI's dedication to advancing open science through transparency, efficiency, and collaboration.

Our renewed agreement with CSAL strengthens support for Swiss universities, ensuring that gold open access publishing remains both accessible and affordable for researchers across Switzerland. Among the institutions participating in this agreement are ETH Zurich and EPFL Lausanne, along with 20 other leading institutions, further expanding the reach and impact of our collaborative efforts.

To date, over 3.9 million researchers have published their findings in MDPI journals, a testament to our role in enhancing Switzerland's position as a hub for university education and research.

Inside MDPI

Celebrating International Women's Day: Accelerating Action

In honour of International Women's Day, MDPI embraced the theme “Accelerate Action,” a global call to advance women's progress by implementing effective strategies and resources. As part of our commitment, we highlighted how open access publishing empowers female voices in research and academia.

Throughout March, we featured original blogs authored by MDPI’s female contributors, showcasing the successes of our journals and employees, and addressing pressing topics such as women's health.

“Open Access supports women in education”

Women Accelerating Action Outside of MDPI

MDPI employee Ana Zdravkovic is accelerating action outside of her MDPI role as a Production Assistant. Working with like-minded women at the award-winning Belgrade-based organization UZOR OsnaŽene (meaning ‘empowered women’), they identify serious flaws in cybersecurity, and help protect women and children against online predators by providing evidence to improve legislation and laws around cyber-attacks.

In this article, we interview Ana, celebrating the important and inspiring work that she and the organisation do.

How Open Access Supports Women in Education

Every day, women and girls face barriers in education or career progression. This is caused by a range of factors, including social expectations, poverty, and poor infrastructure.

Quality opportunities and participation in the education system by women is essential to achieving equality and fulfilling their human rights.

Here, we examine how Open Access supports women in education by removing barriers and ensuring that vital research is accessible.

Recent Advancements in Research on Endometriosis

March is Endometriosis Action Month. Endometriosis is a medical condition affecting women and young girls of reproductive age, often causing symptoms such as severe pelvic pain, irregular periods, and infertility.

More research on endometriosis is still urgently needed.

This research will help develop efficient diagnoses and better treatment for those struggling with the condition.

In this article, we explore what endometriosis is and discuss the latest research advancements on the disease.

We also curated a selection of MDPI journals, articles, and Special Issues focusing on gender equity, women in the workplace, and women’s health.​ Find out more about these by visiting our IWD – Accelerate Action landing page.

As I reflect on the month of March and International Women’s Day, I would like to take a moment to recognize and thank all of the incredible women at MDPI for your dedication to democratizing knowledge and shaping open access. Your contributions are invaluable, and they continue to shape the future of MDPI.

Coming Together for Science

The International Conference on Advanced Remote Sensing (ICARS 2025)

The International Conference on Advanced Remote Sensing (ICARS 2025) took place from 26–28 March 2025, in Barcelona, Spain. It was chaired by Prof. Dr. Fabio Tosti from the Faringdon Research Centre for Non-Destructive Testing and Remote Sensing (UK), Prof. Dr. Andrea Benedetto from University Roma Tre (Italy), and Prof. Dr. Luis Ángel Ruiz from Universitat Politècnica de València (UPV, Spain).

Over three days, the conference explored innovations in Earth and environmental sciences, engineering advancements, and practical applications in biological and agricultural fields.

I am pleased to share that the 1st edition of ICARS 2025 was a great success, with 133 attendees out of 146 registrations. The event featured 43 short talks, 64 posters, and 103 accepted abstracts, along with nine keynote speakers and a major panel with five expert panellists.

Over 60 attendees joined the conference dinner, and the event received outstanding feedback.

The main goal of ICARS2025 was to cover how advanced remote sensing technologies are transforming our approach to global challenges.

Awards

Four awards were presented at the conclusion of the conference, sponsored by the journal Remote Sensing: Best Poster Award (€400), Best Oral Presentation Award (€400), and two Early Career Researcher Awards (1st prize: €600 and 2nd prize: €200).

Thank you to our Partnering Societies

We are grateful for the support of our four partnering societies and nine media partners, who played an important role in promoting the conference. Special thanks to our partnering societies: the European Federation of Geologists (EFG), Geoscience Energy Society of Great Britain (GESGB), Asociación Española de Teledetección (AET) – the Spanish Association of Remote Sensing, and the International Society for Digital Earth (ISDE).

Upcoming In-Person Event

31 March–2 April 2025
Plants 2025: From Seeds to Food Security
Location: Barcelona, Spain

This event will gather plant scientists to discuss the latest research on how to feed a growing population while maintaining a sustainable agro-ecosystem.

Find more upcoming MDPI events here.

Closing Thoughts

MDPI Serbia Salon 2025: A Gathering of Academic Excellence

On Tuesday, 18 March, we successfully concluded our first MDPI Serbia Salon in Belgrade. This event provided a great opportunity to showcase MDPI’s achievements, strengthen connections with the Serbian academic community, and highlight our role as the largest publisher in Serbia. We were honoured to welcome Prof. Dr. Sergej M. Ostojić, Editor-in-Chief of MDPI journal Clinical Bioenergetics, as a guest speaker.

Over the past five years, MDPI has experienced continuous growth in Serbia, with an increasing number of publications, an expansion of Editorial Board memberships, and a greater number of active peer reviewers. The Salon allowed us to express our thanks to the Serbian research community while gathering feedback from attendees representing several major universities.

Discussion topics

As part of the event, I delivered an opening speech highlighting MDPI’s achievements and direction.

The event featured presentations from MDPI colleagues, including discussions on open science, publishing ethics, and our achievements in Serbia.

A special thank-you to all our MDPI presenters, panellists, and organizers who made his event a success. I hope the MDPI Serbia Salon becomes a tradition for years to come, creating connections within the Serbian research community.

Visit to the Science Fund of Serbia and The Ministry of Science

During my visit to Belgrade, I had the opportunity to join my colleagues Emir Ramadani (Operations Manager) and Nevena Blagojev (Journal Relations Manager) in meetings with the Science Fund of Serbia and the Ministry of Science, where we received strong support for our work in Serbia.

Both organizations highly value our presence in and commitment to Serbia, where we employ over 640 staff across our two offices in Belgrade and Novi Sad. We take great pride in creating job opportunities and supporting the community in Serbia.

“There’s a lot of exciting activity happening in MDPI Serbia”

Speaking with our Serbian Colleagues

Finally, I had the opportunity to speak with our Serbian colleagues about our initiatives to expand and to improve our marketing & communication and public relations activities.

It was great to have an open discussion with colleagues – both in person and with the hundreds who joined online.

This visit to Belgrade had been a long time coming for me. Serbia is our largest operation in Europe and there’s a lot of exciting activity happening in MDPI Serbia, including the launch of a new office floor in Novi Sad and the growth and expansion of our teams.

I look forward to returning soon and continuing to support our colleagues across our Serbian offices.

Stefan Tochev
Chief Executive Officer
MDPI AG

28 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Pediatric Oncology” Section


As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Pediatric Oncology” Section, which are listed below:

1. “Rhabdomyosarcoma of the Biliary Tract in Children: Analysis of Single Center Experience”
by Ewa Święszkowska, Dorota Broniszczak, Piotr Kaliciński, Marek Szymczak, Marek Stefanowicz, Wiesława Grajkowska and Bożenna Dembowska-Bagińska
Cancers 2024, 16(17), 3110; https://doi.org/10.3390/cancers16173110
Available online: https://www.mdpi.com/2072-6694/16/17/3110

2. “Progress Toward Epigenetic Targeted Therapies for Childhood Cancer”
by Athanasia Liapodimitri, Ashley R. Tetens, Jordyn Craig-Schwartz, Kayleigh Lunsford, Kegan O. Skalitzky and Michael A. Koldobskiy
Cancers 2024, 16(24), 4149; https://doi.org/10.3390/cancers16244149
Available online: https://www.mdpi.com/2072-6694/16/24/4149

3. “Long-Term Outcomes of Childhood Acute Lymphocytic Leukemia Treated with Adapted Berlin–Frankfurt–Münster (BFM) Protocols: A Multicentric Analysis from a Developing Country”
by Patricia Regina Cavalcanti Barbosa Horn, Marilza de Moura Ribeiro-Carvalho, Alice Maria Boulhosa de Azevedo, Adriana Martins de Sousa, Simone Faria, Cristina Wiggers, Soraia Rouxinol, Marcia Trindade Schramm, Bárbara Sarni Sanches, Nathalia Lopez Duarte et al.
Cancers 2024, 16(16), 2898; https://doi.org/10.3390/cancers16162898
Available online: https://www.mdpi.com/2072-6694/16/16/2898

4. “Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia (AcuPA Study): A Nationwide Survey in Poland”
by Anna Morawiak, Małgorzata Salamonowicz-Bodzioch, Aleksandra Królak, Krzysztof Kałwak, Joanna Owoc-Lempach, Jerzy Kowalczyk, Joanna Zawitkowska, Tomasz Szczepański, Ninela Irga-Jaworska, Elżbieta Adamkiewicz-Drożyńska et al.
Cancers 2024, 16(15), 2640; https://doi.org/10.3390/cancers16152640
Available online: https://www.mdpi.com/2072-6694/16/15/2640

5. “Efficacy and Safety of Acupuncture and Related Techniques in the Management of Oncological Children and Adolescent Patients: A Systematic Review”
by Esther Martínez García, M. Betina Nishishinya Aquino, Ofelia Cruz Martínez, Yiming Ren, Ruyu Xia, Yutong Fei and Carles Fernández-Jané
Cancers 2024, 16(18), 3197; https://doi.org/10.3390/cancers16183197
Available online: https://www.mdpi.com/2072-6694/16/18/3197

6. “Panobinostat Synergizes with Chemotherapeutic Agents and Improves Efficacy of Standard-of-Care Chemotherapy Combinations in Ewing Sarcoma Cells”
by Kaitlyn H. Smith, Erin M. Trovillion, Chloe Sholler, Divya Gandra, Kimberly Q. McKinney, David Mulama, Karl J. Dykema, Abhinav B. Nagulapally, Javier Oesterheld and Giselle L. Saulnier Sholler
Cancers 2024, 16(21), 3565; https://doi.org/10.3390/cancers16213565
Available online: https://www.mdpi.com/2072-6694/16/21/3565

7. “Characterization of Patient Activation among Childhood Cancer Survivors in the St. Jude Lifetime Cohort Study (SJLIFE)”
by Megan E. Ware, Angelica De La Cruz, Qian Dong, Kyla Shelton, Tara M. Brinkman, I-Chan Huang, Rachel Webster, Brian Potter, Kevin Krull, Sedigheh Mirzaei et al.
Cancers 2024, 16(18), 3220; https://doi.org/10.3390/cancers16183220
Available online: https://www.mdpi.com/2072-6694/16/18/3220

8. “VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma”
by Natalia Muñoz Perez, Juliana M. Pensabene, Phillip M. Galbo, Jr., Negar Sadeghipour, Joanne Xiu, Kirsten Moziak, Rita M. Yazejian, Rachel L. Welch, W. Robert Bell, Soma Sengupta et al.
Cancers 2024, 16(15), 2629; https://doi.org/10.3390/cancers16152629
Available online: https://www.mdpi.com/2072-6694/16/15/2629

9. “Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study”
by Stefano Mastrangelo, Giorgio Attinà, Guido Rindi, Alberto Romano, Palma Maurizi and Antonio Ruggiero
Cancers 2024, 16(20), 3440; https://doi.org/10.3390/cancers16203440
Available online: https://www.mdpi.com/2072-6694/16/20/3440

10. “Impaired DNA Double-Strand Break Repair in Irradiated Sheep Lung Fibroblasts: Late Effects of Previous Irradiation of the Spinal Thecal Sac”
by Bassem Youssef, Charbel Feghaly, Joelle Al Choboq, Jolie Bou-Gharios, Rafka Challita, Joyce Azzi, Hanine Bou Hadir, Fabienne Abi Antoun, Tarek Araji, Phillip J. Taddei et al.
Cancers 2024, 16(17), 2968; https://doi.org/10.3390/cancers16172968
Available online: https://www.mdpi.com/2072-6694/16/17/2968

11. “Integrated Psychological Services in Pediatric Oncology: Caregiver Perspectives at Diagnosis”
by Emily Bernstein, Anna M. Jones, Niki Jurbergs, Jennifer L. Harman, Sean Phipps and R. Elyse Heidelberg
Cancers 2024, 16(18), 3137; https://doi.org/10.3390/cancers16183137
Available online: https://www.mdpi.com/2072-6694/16/18/3137

12. “Non-Syndromic and Syndromic Defects in Children with Extracranial Germ Cell Tumors: Data of 2610 Children Registered with the German MAKEI 96/MAHO 98 Registry Compared to the General Population”
by Judit H. Schultewolter, Anke Rissmann, Dietrich von Schweinitz, Michael Frühwald, Claudia Blattmann, Lars Fischer, Björn Sönke Lange, Rüdiger Wessalowski, Birgit Fröhlich, Wolfgang Behnisch et al.
Cancers 2024, 16(11), 2157; https://doi.org/10.3390/cancers16112157
Available online: https://www.mdpi.com/2072-6694/16/11/2157

13. “Telomere Length in Adolescent and Young Adult Survivors of Childhood Cancer”
by Meerim Park, Dong-Eun Lee, Yuna Hong, Jin Kyung Suh, Jun Ah Lee, Myungshin Kim and Hyeon Jin Park
Cancers 2024, 16(13), 2344; https://doi.org/10.3390/cancers16132344
Available online: https://www.mdpi.com/2072-6694/16/13/2344

14. “Rare Oncogenic Fusions in Pediatric Central Nervous System Tumors: A Case Series and Literature Review”
by Melek Ahmed, Anne Sieben, Toon Van Genechten, Sasha Libbrecht, Nathalie Gilis, Mania De Praeter, Christophe Fricx, Pierluigi Calò, Claude Van Campenhout, Nicky D’Haene et al.
Cancers 2024, 16(19), 3344; https://doi.org/10.3390/cancers16193344
Available online: https://www.mdpi.com/2072-6694/16/19/3344

15. “Therapeutic Parent–Child Communication and Health Outcomes in the Childhood Cancer Context: A Scoping Review”
by Heeyeon Son and Nani Kim
Cancers 2024, 16(11), 2152; https://doi.org/10.3390/cancers16112152
Available online: https://www.mdpi.com/2072-6694/16/11/2152

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

25 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the Section “Cancer Drug Development”


As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the Section “Cancer Drug Development”, which are listed below.

1. “Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer”
by Maria George Elias, Shadma Fatima, Timothy J. Mann, Shawan Karan, Meena Mikhael, Paul de Souza, Christopher P. Gordon, Kieran F. Scott and Janice R. Aldrich-Wright
Cancers 2024, 16(14), 2544; https://doi.org/10.3390/cancers16142544
Available online: https://www.mdpi.com/2072-6694/16/14/2544

2. “A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers”
by Lorenzo Magrassi, Giulia Pinton, Sabino Luzzi, Sergio Comincini, Andrea Scravaglieri, Valentina Gigliotti, Bianca Laura Bernardoni, Ilaria D’Agostino, Francesca Juretich, Concettina La Motta et al.
Cancers 2024, 16(13), 2397; https://doi.org/10.3390/cancers16132397
Available online: https://www.mdpi.com/2072-6694/16/13/2397

3. “Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer”
by Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa et al.
Cancers 2024, 16(14), 2545; https://doi.org/10.3390/cancers16142545
Available online: https://www.mdpi.com/2072-6694/16/14/2545

4. “Dose Optimization of Targeted Therapies for Oncologic Indications”
by Marjorie E. Zettler
Cancers 2024, 16(12), 2180; https://doi.org/10.3390/cancers16122180
Available online: https://www.mdpi.com/2072-6694/16/12/2180

5. “The Anticancer Application of Delivery Systems for Honokiol and Magnolol”
by Katarzyna Dominiak, Aleksandra Gostyńska, Michał Szulc and Maciej Stawny
Cancers 2024, 16(12), 2257; https://doi.org/10.3390/cancers16122257
Available online: https://www.mdpi.com/2072-6694/16/12/2257

6. “Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment”
by Taufeeque Ali, Daniel Li, Thilini Nimasha Fernando Ponnamperumage, Alexis Kimberly Peterson, Jatin Pandey, Kulsum Fatima, John Brzezinski, Julia Anna Rose Jakusz, Hanlun Gao, Gilbert Edward Koelsch et al.
Cancers 2024, 16(12), 2171; https://doi.org/10.3390/cancers16122171
Available online: https://www.mdpi.com/2072-6694/16/12/2171

7. “Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives”
by Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini and Manuela Ferracin
Cancers 2024, 16(15), 2752; https://doi.org/10.3390/cancers16152752
Available online: https://www.mdpi.com/2072-6694/16/15/2752

8. “Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development”
by Whi-An Kwon, Seo-Yeon Lee, Tae Yoong Jeong, Hyeon Hoe Kim and Min-Kyung Lee
Cancers 2024, 16(13), 2420; https://doi.org/10.3390/cancers16132420
Available online: https://www.mdpi.com/2072-6694/16/13/2420

9. “Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines”
by Nicole Ferrario, Emanuela Marras, Veronica Vivona, Federica Randisi, Antonino Nicolò Fallica, Agostino Marrazzo, Gianpaolo Perletti and Marzia Bruna Gariboldi
Cancers 2024, 16(12), 2227; https://doi.org/10.3390/cancers16122227
Available online: https://www.mdpi.com/2072-6694/16/12/2227

10. “Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review”
by Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, Donal Buggy, Oscar Diaz-Cambronero, Mats Enlund, Patrice Forget, Anil Gupta, Markus W. Hollmann, Daniela Ionescu et al.
Cancers 2024, 16(13), 2304; https://doi.org/10.3390/cancers16132304
Available online: https://www.mdpi.com/2072-6694/16/13/2304

11. “Target-Driven Tissue-Agnostic Drug Approvals—A New Path of Drug Development”
by Kyaw Z. Thein, Yin M. Myat, Byung S. Park, Kalpana Panigrahi and Shivaani Kummar
Cancers 2024, 16(14), 2529; https://doi.org/10.3390/cancers16142529
Available online: https://www.mdpi.com/2072-6694/16/14/2529

12. “Overcoming Chemoresistance in Cancer: The Promise of Crizotinib”
by Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya and Jamal Mahajna
Cancers 2024, 16(13), 2479; https://doi.org/10.3390/cancers16132479
Available online: https://www.mdpi.com/2072-6694/16/13/2479

13. “Molecular Interactions of the Plant Steroid Hormone Epibrassinolide on Human Drug-Sensitive and Drug-Resistant Small-Cell Lung Carcinoma Cells”
by David Sadava and Shiuan Chen
Cancers 2024, 16(22), 3812; https://doi.org/10.3390/cancers16223812
Available online: https://www.mdpi.com/2072-6694/16/22/3812

14. “Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies”
by Christiana Mo, Michelle Sterpi, Hyein Jeon and Fernand Bteich
Cancers 2024, 16(16), 2854; https://doi.org/10.3390/cancers16162854
Available online: https://www.mdpi.com/2072-6694/16/16/2854

15. “Genotoxic and Anti-Migratory Effects of Camptothecin Combined with Celastrol or Resveratrol in Metastatic and Stem-like Cells of Colon Cancer”
by Helena Moreira, Anna Szyjka, Dorota Bęben, Oliwia Siwiela, Anna Radajewska, Nadia Stankiewicz, Małgorzata Grzesiak, Benita Wiatrak, Fathi Emhemmed, Christian D. Muller et al.
Cancers 2024, 16(19), 3279; https://doi.org/10.3390/cancers16193279
Available online: https://www.mdpi.com/2072-6694/16/19/3279

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

25 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Tumor Microenvironment” Section


As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Tumor Microenvironment” Section, which are listed below:

1. “TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications”
by Chuqi Wang, Jordan Yong Ming Tan, Nishtha Chitkara and Shruti Bhatt
Cancers 202416(17), 3069; https://doi.org/10.3390/cancers16173069
Available online: https://www.mdpi.com/2072-6694/16/17/3069

2. “The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View”
by Federico Mosna
Cancers 202416(13), 2359; https://doi.org/10.3390/cancers16132359
Available online: https://www.mdpi.com/2072-6694/16/13/2359

3. “Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions”
by Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino and Vanessa Desantis
Cancers 202416(13), 2438; https://doi.org/10.3390/cancers16132438
Available online: https://www.mdpi.com/2072-6694/16/13/2438

4. “Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems”
by Dragana Nikitovic, Ekaterina Kukovyakina, Aikaterini Berdiaki, Alexandros Tzanakakis, Anna Luss, Elizaveta Vlaskina, Anne Yagolovich, Aristides Tsatsakis and Andrey Kuskov
Cancers 202416(22), 3768; https://doi.org/10.3390/cancers16223768
Available online: https://www.mdpi.com/2072-6694/16/22/3768

5. “Antibody-Based Therapies for Peripheral T-Cell Lymphoma”
by Nazila Shafagati, Suman Paul, Sima Rozati and Cole H. Sterling
Cancers 202416(20), 3489; https://doi.org/10.3390/cancers16203489
Available online: https://www.mdpi.com/2072-6694/16/20/3489

6. “Importance of Michaelis Constants for Cancer Cell Redox Balance and Lactate Secretion—Revisiting the Warburg Effect”
by Michael Niepmann
Cancers 202416(13), 2290; https://doi.org/10.3390/cancers16132290
Available online: https://www.mdpi.com/2072-6694/16/13/2290

7. “Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance”
by Abdulaziz M. Eshaq, Thomas W. Flanagan, Sofie-Yasmin Hassan, Sara A. Al Asheikh, Waleed A. Al-Amoudi, Simeon Santourlidis, Sarah-Lilly Hassan, Maryam O. Alamodi, Marcelo L. Bendhack, Mohammed O. Alamodi et al.
Cancers 202416(15), 2754; https://doi.org/10.3390/cancers16152754
Available online: https://www.mdpi.com/2072-6694/16/15/2754

8. “Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma”
by Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, Tatsunori Shimoi, Akiko Miyagi Maeshima, Kotaro Umamoto, Akihiko Shimomura, Chikako Shimizu, Yuto Yamazaki, Eijiro Nakamura et al.
Cancers 202416(12), 2191; https://doi.org/10.3390/cancers16122191
Available online: https://www.mdpi.com/2072-6694/16/12/2191

9. “Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies”
by Patrizia Limonta, Raffaella Chiaramonte and Lavinia Casati
Cancers 202416(16), 2861; https://doi.org/10.3390/cancers16162861
Available online: https://www.mdpi.com/2072-6694/16/16/2861

10. “Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component”
by Hubert Pakula, Filippo Pederzoli, Giuseppe Nicolò Fanelli, Pier Vitale Nuzzo, Silvia Rodrigues and Massimo Loda
Cancers 202416(21), 3685; https://doi.org/10.3390/cancers16213685
Available online: https://www.mdpi.com/2072-6694/16/21/3685

11. “A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder”
by Carmen Keim-del Pino, Pablo Ramos-García and Miguel Ángel González-Moles
Cancers 202416(15), 2614; https://doi.org/10.3390/cancers16152614
Available online: https://www.mdpi.com/2072-6694/16/15/2614

12. “Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour”
by Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, Joana Liz-Pimenta, Joana Assis, Deolinda Pereira and Rui Medeiros
Cancers 202416(13), 2356; https://doi.org/10.3390/cancers16132356
Available online: https://www.mdpi.com/2072-6694/16/13/2356

13. “Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment”
by Anghesom Ghebremedhin, Dipti Athavale, Yanting Zhang, Xiaodan Yao, Curt Balch and Shumei Song
Cancers 202416(19), 3410; https://doi.org/10.3390/cancers16193410
Available online: https://www.mdpi.com/2072-6694/16/19/3410

14 “Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance”
by Shauna McClelland, Pamela J. Maxwell, Cristina Branco, Simon T. Barry, Cath Eberlein and Melissa J. LaBonte
Cancers 202416(16), 2797; https://doi.org/10.3390/cancers16162797
Available online: https://www.mdpi.com/2072-6694/16/16/2797

15. “Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917”
by Georgette A. Radford, Laura Vrbanac, Rebekah T. de Nys, Daniel L. Worthley, Josephine A. Wright, Jeff Hasty and Susan L. Woods
Cancers 2024, 16(17), 2971; https://doi.org/10.3390/cancers16172971
Available online: https://www.mdpi.com/2072-6694/16/17/2971

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

25 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Infectious Agents and Cancer” Section


As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Infectious Agents and Cancer” Section, which are listed below:

1. “Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection”
by Pompilia Radu, Chiara Becchetti, Jonas Schropp, Patrick Schmid, Patrizia Künzler-Heule, Joachim Mertens, Darius Moradpour, Beat Müllaupt, David Semela, Francesco Negro et al.
Cancers 202416(14), 2573; https://doi.org/10.3390/cancers16142573
Available online: https://www.mdpi.com/2072-6694/16/14/2573

2. “Dihydrotestosterone Enhances MICA-Mediated Immune Responses to Epstein–Barr Virus-Associated Gastric Carcinoma”
by Donghyun Seo, Hyeji Byun, Miyeon Cho, Sun Hee Lee, Sohyun Youn, Junho Lee, Inuk Jung, Hyosun Cho and Hyojeung Kang
Cancers 202416(18), 3219; https://doi.org/10.3390/cancers16183219
Available online: https://www.mdpi.com/2072-6694/16/18/3219

3. “Vaginal Intraepithelial Neoplasia (VaIN) after Hysterectomy Is Strongly Associated with Persistent HR-HPV Infection”
by Maria Teresa Bruno, Marco Marzio Panella, Gaetano Valenti, Salvatore Di Grazia, Francesco Sgalambro, Jessica Farina, Miriam Previti and Liliana Mereu
Cancers 202416(14), 2524; https://doi.org/10.3390/cancers16142524
Available online: https://www.mdpi.com/2072-6694/16/14/2524

4. “Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies”
by Ziyao Lu, Shahab Haghollahi and Muhammad Afzal
Cancers 202416(20), 3474; https://doi.org/10.3390/cancers16203474
Available online: https://www.mdpi.com/2072-6694/16/20/3474

5. “A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer”
by Xu Xu, Shih-Long Yan, Yi-Te Yo, Peiyu Chiang, Chan-Yen Tsai, Lih-Ling Lin and Albert Qin
Cancers 202416(17), 3052; https://doi.org/10.3390/cancers16173052
Available online: https://www.mdpi.com/2072-6694/16/17/3052

6. “HPV and Lung Cancer: A Systematic Review”
by Telma Sequeira, Rui Pinto, Carlos Cardoso, Catarina Almeida, Rita Aragão, Teresa Almodovar, Manuel Bicho, Maria Clara Bicho and Cristina Bárbara
Cancers 202416(19), 3325; https://doi.org/10.3390/cancers16193325
Available online: https://www.mdpi.com/2072-6694/16/19/3325

7. “De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction”
by Clinton Wu, Paulina Kuzmin and Ricklie Julian
Cancers 202416(15), 2733; https://doi.org/10.3390/cancers16152733
Available online: https://www.mdpi.com/2072-6694/16/15/2733

8. “The Intersection of the Oral Microbiome and Salivary Metabolites in Head and Neck Cancer: From Diagnosis to Treatment”
by Maria Gonzalez Agurto, Nicolas Olivares, Gisela Canedo-Marroquin, Daniela Espinoza and Sofia C. Tortora
Cancers 202416(20), 3545; https://doi.org/10.3390/cancers16203545
Available online: https://www.mdpi.com/2072-6694/16/20/3545

9. “The Impact of Urine-Sample HPV Testing on the Effectiveness of Screening for Cervical Cancer: An Umbrella Review”
by Wojciech Miazga, Tomasz Tatara, Katarzyna Wnuk, Mariusz Gujski, Jarosław Pinkas and Urszula Religioni
Cancers 202416(12), 2244; https://doi.org/10.3390/cancers16122244
Available online: https://www.mdpi.com/2072-6694/16/12/2244

10. “Functional Targets for Epstein-Barr Virus BART MicroRNAs in B Cell Lymphomas”
by Devin N. Fachko, Bonnie Goff, Yan Chen and Rebecca L. Skalsky
Cancers 202416(20), 3537; https://doi.org/10.3390/cancers16203537
Available online: https://www.mdpi.com/2072-6694/16/20/3537

11. “Tumor-Associated Edema in Children with Kaposi Sarcoma: 14 Years’ Experience at Kamuzu Central Hospital, Lilongwe, Malawi”
by Fatsani Rose Manase, Allison Silverstein, William Kamiyango, Jimmy Villiera, Clement Dziwe, Claudia Wallrauch, Tom Heller, Mark Zobeck, Tamiwe Tomoka, Michael E. Scheurer et al.
Cancers 202416(22), 3769; https://doi.org/10.3390/cancers16223769
Available online: https://www.mdpi.com/2072-6694/16/22/3769

12. “Role of Artificial Intelligence in Human Papillomavirus Status Prediction for Oropharyngeal Cancer: A Scoping Review”
by Andrea Migliorelli, Marianna Manuelli, Andrea Ciorba, Francesco Stomeo, Stefano Pelucchi and Chiara Bianchini
Cancers 202416(23), 4040; https://doi.org/10.3390/cancers16234040
Available online: https://www.mdpi.com/2072-6694/16/23/4040

13. “Evaluation of Automatic Signal Detection of In Situ Hybridization for Detecting HPV DNA in Cervical Tissue Derived from Patients with Cervical Intraepithelial Neoplasia”
by Marcin Przybylski, Sonja Millert-Kalińska, Mateusz de Mezer, Monika Krzyżaniak, Paweł Kurzawa, Jakub Żurawski, Robert Jach and Dominik Pruski
Cancers 202416(20), 3485; https://doi.org/10.3390/cancers16203485
Available online: https://www.mdpi.com/2072-6694/16/20/3485

14 “Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study”
by Efthymios Ladoukakis, Tim Oliver, Mark Wilks, Emily F. Lane, Frank Chinegwundoh, Greg Shaw and Belinda Nedjai
Cancers 202517(1), 70; https://doi.org/10.3390/cancers17010070
Available online: https://www.mdpi.com/2072-6694/17/1/70

15. “Hepatitis B Virus-Induced Resistance to Sorafenib and Lenvatinib in Hepatocellular Carcinoma Cells: Implications for Cell Viability and Signaling Pathways”
by Narmen Esmael,Ido Lubin,Ran Tur-Kaspa and Romy Zemel
Cancers 202416(22), 3763; https://doi.org/10.3390/cancers16223763
Available online: https://www.mdpi.com/2072-6694/16/22/3763

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

24 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Cancer Metastasis” Section


As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Metastasis” Section, which are listed below:

1. “Comparative Efficacy of Adagrasib and Sotorasib in KRAS G12C-Mutant NSCLC: Insights from Pivotal Trials”
by Tzu-Rong Peng,Ta-Wei Wu,Tai-Yung Yi and An-Jan Wu
Cancers 2024, 16(21), 3676; https://doi.org/10.3390/cancers16213676
Available online: https://www.mdpi.com/2072-6694/16/21/3676

2. “FBXO11 Mediates Ubiquitination of ZEB1 and Modulates Epithelial to Mesenchymal Transition in Lung Cancer Cells”
by Xinyue Zhao, Zhihui Han, Ruiying Liu, Zehao Li, Ling Mei and Yue Jin
Cancers 2024, 16(19), 3269; https://doi.org/10.3390/cancers16193269
Available online: https://www.mdpi.com/2072-6694/16/19/3269

3. “Prevention of Brain Metastases: A New Frontier”
by Alessia Pellerino, Tara Marie Davidson, Shreyas S. Bellur, Manmeet S. Ahluwalia, Hussein Tawbi, Roberta Rudà and Riccardo Soffietti
Cancers 2024, 16(11), 2134; https://doi.org/10.3390/cancers16112134
Available online: https://www.mdpi.com/2072-6694/16/11/2134

4. “High M2-TAM Infiltration and STAT3/NF-?B Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer”
by George Alexandre Lira, Fábio Medeiros de Azevedo, Ingrid Gabrielle dos Santos Lins, Isabelle de Lima Marques, Giovanna Afonso Lira, Christina Eich and Raimundo Fernandes de Araujo Junior
Cancers 2024, 16(14), 2496; https://doi.org/10.3390/cancers16142496
Available online: https://www.mdpi.com/2072-6694/16/14/2496

5. “Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma”
by Risky Oktriani, Anna Chiara Pirona, Lili Kalmár, Ariani S. Rahadian, Beiping Miao, Andrea S. Bauer, Jörg D. Hoheisel, Michael Boettcher and Haoqi Du
Cancers 2024, 16(21), 3684; https://doi.org/10.3390/cancers16213684
Available online: https://www.mdpi.com/2072-6694/16/21/3684

6. “Exposed Phosphatidylserine as a Biomarker for Clear Identification of Breast Cancer Brain Metastases in Mouse Models”
by Lulu Wang, Alan H. Zhao, Chad A. Arledge, Fei Xing, Michael D. Chan, Rolf A. Brekken, Amyn A. Habib and Dawen Zhao
Cancers 2024, 16(17), 3088; https://doi.org/10.3390/cancers16173088
Available online: https://www.mdpi.com/2072-6694/16/17/3088

7. “Navigating Brain Metastases: Unveiling the Potential of 3-Tesla Intraoperative Magnetic Resonance Imaging”
by Ghaith Altawalbeh, Maria Goldberg, Michel Gustavo Mondragón-Soto, Chiara Negwer, Arthur Wagner, Jens Gempt, Bernhard Meyer and Amir Kaywan Aftahy
Cancers 2024, 16(16), 2774; https://doi.org/10.3390/cancers16162774
Available online: https://www.mdpi.com/2072-6694/16/16/2774

8. “Tracing Quiescent Cancer Cells In Vivo”
by Moon Jong Kim
Cancers 2024, 16(22), 3822; https://doi.org/10.3390/cancers16223822
Available online: https://www.mdpi.com/2072-6694/16/22/3822

9. “Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases—A Cohort Study”
by Estefania Serra, Álvaro Abarzua-Araya, Ana Arance, Roberto Martin-Huertas, Francisco Aya, María Lourdes Olondo, Daniel Rizo-Potau, Josep Malvehy, Susana Puig, Cristina Carrera et al.
Cancers 2024, 16(12), 2272; https://doi.org/10.3390/cancers16122272
Available online: https://www.mdpi.com/2072-6694/16/12/2272

10. “TSH Stimulation before PET/CT as Our Frenemy in Detecting Thyroid Cancer Metastases—Final Results of a Retrospective Analysis”
by Maciej Kołodziej, Marek Saracyn, Arkadiusz Lubas, Dorota Brodowska-Kania, Andrzej Mazurek, Mirosław Dziuk, Adam Daniel Durma, Stanisław Niemczyk and Grzegorz Kamiński
Cancers 2024, 16(19), 3413; https://doi.org/10.3390/cancers16193413
Available online: https://www.mdpi.com/2072-6694/16/19/3413

11. “Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence”
by Yasuyuki Shigematsu, Rumiko Saito, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Shunji Takahashi and Kentaro Inamura
Cancers 2024, 16(17), 3003; https://doi.org/10.3390/cancers16173003
Available online: https://www.mdpi.com/2072-6694/16/17/3003

12. “Microbiome—Stealth Regulator of Breast Homeostasis and Cancer Metastasis”
by Saori Furuta
Cancers 2024, 16(17), 3040; https://doi.org/10.3390/cancers16173040
Available online: https://www.mdpi.com/2072-6694/16/17/3040

13. “Emerging Paradigms in Cancer Metastasis: Ghost Mitochondria, Vasculogenic Mimicry, and Polyploid Giant Cancer Cells”
by Mateusz Krotofil, Maciej Tota, Jakub Siednienko and Piotr Donizy
Cancers 2024, 16(20), 3539; https://doi.org/10.3390/cancers16203539
Available online: https://www.mdpi.com/2072-6694/16/20/3539

14.“The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer”
by David Han, Jonathan M. Spehar, Dillon S. Richardson, Sumudu Leelananda, Prathik Chakravarthy, Samantha Grecco, Jesse Reardon, Daniel G. Stover, Chad Bennett, Gina M. Sizemore et al.
Cancers 2024, 16(17), 3043; https://doi.org/10.3390/cancers16173043
Available online: https://www.mdpi.com/2072-6694/16/17/3043

15. “Role of Podoplanin (PDPN) in Advancing the Progression and Metastasis of Glioblastoma Multiforme (GBM)”
by Bharti Sharma,George Agriantonis,Zahra Shafaee, Kate Twelker, Navin D. Bhatia, Zachary Kuschner, Monique Arnold, Aubrey Agcon, Jasmine Dave, Juan Mestre et al.
Cancers 2024, 16(23), 4051; https://doi.org/10.3390/cancers16234051
Available online: https://www.mdpi.com/2072-6694/16/23/4051

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

21 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Cancer Epidemiology and Prevention” Section


As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Epidemiology and Prevention” Section, which are listed below.

1. “Microplastics in the Human Body: Exposure, Detection, and Risk of Carcinogenesis: A State-of-the-Art Review”
by Eliasz Dzierżyński, Piotr J. Gawlik, Damian Puźniak, Wojciech Flieger, Katarzyna Jóźwik, Grzegorz Teresiński, Alicja Forma, Paulina Wdowiak, Jacek Baj and Jolanta Flieger
Cancers 2024, 16(21), 3703; https://doi.org/10.3390/cancers16213703
Available online: https://www.mdpi.com/2072-6694/16/21/3703

2. “Trends in Cancer Incidence and Mortality in US Adolescents and Young Adults, 2016–2021”
by Li Zhang, Joshua E. Muscat, Vernon M. Chinchilli and Chandrika G. Behura
Cancers 2024, 16(18), 3153; https://doi.org/10.3390/cancers16183153
Available online: https://www.mdpi.com/2072-6694/16/18/3153

3. “Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies”
by Siva Dallavalasa, SubbaRao V. Tulimilli, Vidya G. Bettada, Medha Karnik, Chinnappa A. Uthaiah, Preethi G. Anantharaju, Suma M. Nataraj, Rajalakshmi Ramashetty, Olga A. Sukocheva, Edmund Tse et al.
Cancers 2024, 16(18), 3211; https://doi.org/10.3390/cancers16183211
Available online: https://www.mdpi.com/2072-6694/16/18/3211

4. “Effects of Weight Loss on Key Obesity-Related Biomarkers Linked to the Risk of Endometrial Cancer: A Systematic Review and Meta-Analysis”
by Angela D. Clontz, Emma Gan, Stephen D. Hursting and Victoria L. Bae-Jump
Cancers 2024, 16(12), 2197; https://doi.org/10.3390/cancers16122197
Available online: https://www.mdpi.com/2072-6694/16/12/2197

5. “Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000–2020 French Cohort”
by Clemence Basse, Matthieu Carton, Maud Milder, Romain Geiss, Pauline Du Rusquec, Catherine Daniel, Marie-Ange Massiani, Alain Livartowski and Nicolas Girard
Cancers 2024, 16(15), 2768; https://doi.org/10.3390/cancers16152768
Available online: https://www.mdpi.com/2072-6694/16/15/2768

6. “Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment”
by Laia Lorenzo-Esteller, Raúl Ramos-Polo, Alexandra Pons Riverola, Herminio Morillas, Javier Berdejo, Sonia Pernas, Helena Pomares, Leyre Asiain, Alberto Garay, Evelyn Martínez Pérez et al.
Cancers 2024, 16(20), 3466; https://doi.org/10.3390/cancers16203466
Available online: https://www.mdpi.com/2072-6694/16/20/3466

7. “Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms”
by Anna Markowska, Michał Antoszczak, Janina Markowska and Adam Huczyński
Cancers 2024, 16(12), 2288; https://doi.org/10.3390/cancers16122288
Available online: https://www.mdpi.com/2072-6694/16/12/2288

8. “A Comprehensive Analysis of Skin Cancer Concerns and Protective Practices in Manitoba, Canada, Highlights Lack of Skin Cancer Awareness and Predominance of High-Risk Sun Exposure Behaviors”
by François Lagacé, Santina Conte, Lorena A. Mija, Amina Moustaqim-Barrette, Farhan Mahmood, Jonathan LeBeau, Alyson McKenna, Mahan Maazi, Johnny Hanna, Alexandra Sarah Victoria Kelly et al.
Cancers 2024, 16(17), 3093; https://doi.org/10.3390/cancers16173093
Available online: https://www.mdpi.com/2072-6694/16/17/3093

9. “The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer”
by Woong Ki Park, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Jai Min Ryu and Byung Joo Chae
Cancers 2024, 16(14), 2566; https://doi.org/10.3390/cancers16142566
Available online: https://www.mdpi.com/2072-6694/16/14/2566

10. “The Application of High-Frequency Ultrasonography in Post-Therapeutic Assessment of Actinic Keratosis After Photodynamic Therapy”
by Katarzyna Korecka, Anna Slian, Joanna Czajkowska, Aleksandra Dańczak-Pazdrowska and Adriana Polańska
Cancers 2024, 16(22), 3778; https://doi.org/10.3390/cancers16223778
Available online: https://www.mdpi.com/2072-6694/16/22/3778

11. “Lung Cancer and Interstitial Lung Diseases”
by Fotios Drakopanagiotakis, Ekaterina Krauss, Ira Michailidou, Vasileios Drosos, Stavros Anevlavis, Andreas Günther and Paschalis Steiropoulos
Cancers 2024, 16(16), 2837; https://doi.org/10.3390/cancers16162837
Available online: https://www.mdpi.com/2072-6694/16/16/2837

12. “Trends and Age–Period–Cohort Effect on the Incidence of Early-Onset Colorectal Cancer (20–44 Years) from 1990 to 2021 in the United States”
by Wafa A. Aldhaleei, Michael B. Wallace and Akshaya Srikanth Bhagavathula
Cancers 2024, 16(16), 2883; https://doi.org/10.3390/cancers16162883
Available online: https://www.mdpi.com/2072-6694/16/16/2883

13. “The Association between Medroxyprogesterone Acetate Exposure and Meningioma”
by Russell L. Griffin
Cancers 2024, 16(19), 3362; https://doi.org/10.3390/cancers16193362
Available online: https://www.mdpi.com/2072-6694/16/19/3362

14. “Imaging Biomarkers of Oral Dysplasia and Carcinoma Measured with In Vivo Endoscopic Optical Coherence Tomography”
by Jeanie Malone, Chloe Hill, Adrian Tanskanen, Kelly Liu, Samson Ng, Calum MacAulay, Catherine F. Poh and Pierre M. Lane
Cancers 2024, 16(15), 2751; https://doi.org/10.3390/cancers16152751
Available online: https://www.mdpi.com/2072-6694/16/15/2751

15. “SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells”
by Marco Colella, Andrea Iannucci, Claudia Maresca, Francesco Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone and Giovanni Monteleone
Cancers 2024, 16(13), 2370; https://doi.org/10.3390/cancers16132370
Available online: https://www.mdpi.com/2072-6694/16/13/2370

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Back to TopTop